Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 37 | 2024 | 5195 | 1.540 |
Why?
|
Urea | 2 | 2013 | 448 | 0.440 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2013 | 664 | 0.400 |
Why?
|
Morpholines | 1 | 2014 | 584 | 0.370 |
Why?
|
Boronic Acids | 9 | 2014 | 915 | 0.370 |
Why?
|
Oligopeptides | 4 | 2024 | 1194 | 0.370 |
Why?
|
Phosphorylcholine | 1 | 2010 | 153 | 0.330 |
Why?
|
Pyrazines | 9 | 2014 | 1206 | 0.330 |
Why?
|
Pyrazoles | 4 | 2015 | 2029 | 0.320 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2063 | 0.290 |
Why?
|
Apoptosis | 15 | 2017 | 9528 | 0.270 |
Why?
|
Osteoblasts | 6 | 2016 | 1153 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2460 | 0.250 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2014 | 3621 | 0.240 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2017 | 2892 | 0.240 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2024 | 2960 | 0.230 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2024 | 11886 | 0.230 |
Why?
|
Sirolimus | 2 | 2014 | 1540 | 0.230 |
Why?
|
Cell Line, Tumor | 22 | 2015 | 17174 | 0.220 |
Why?
|
Thalidomide | 4 | 2014 | 886 | 0.210 |
Why?
|
Antineoplastic Agents | 9 | 2015 | 13699 | 0.210 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2015 | 423 | 0.200 |
Why?
|
Osteoclasts | 5 | 2014 | 713 | 0.200 |
Why?
|
Dexamethasone | 3 | 2024 | 1965 | 0.190 |
Why?
|
Mice, SCID | 11 | 2016 | 2631 | 0.190 |
Why?
|
Hydroxamic Acids | 2 | 2015 | 483 | 0.180 |
Why?
|
Pyrimidines | 4 | 2015 | 3050 | 0.180 |
Why?
|
Activins | 2 | 2013 | 211 | 0.170 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2015 | 778 | 0.160 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7609 | 0.160 |
Why?
|
Signal Transduction | 8 | 2017 | 23652 | 0.160 |
Why?
|
Bone Marrow Cells | 6 | 2012 | 2414 | 0.150 |
Why?
|
Osteolysis | 2 | 2011 | 274 | 0.150 |
Why?
|
Histone Deacetylases | 2 | 2013 | 718 | 0.150 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2016 | 1658 | 0.140 |
Why?
|
Drug Synergism | 5 | 2015 | 1762 | 0.140 |
Why?
|
Bone Remodeling | 2 | 2011 | 583 | 0.130 |
Why?
|
Decorin | 1 | 2015 | 38 | 0.120 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2015 | 719 | 0.120 |
Why?
|
Mice | 23 | 2016 | 82074 | 0.120 |
Why?
|
Plasmacytoma | 2 | 2014 | 170 | 0.120 |
Why?
|
Cell Proliferation | 9 | 2014 | 10486 | 0.120 |
Why?
|
Casein Kinase Ialpha | 1 | 2014 | 26 | 0.120 |
Why?
|
Enzyme Activation | 5 | 2012 | 3588 | 0.110 |
Why?
|
Chemokine CCL3 | 2 | 2011 | 85 | 0.110 |
Why?
|
Phosphorylation | 4 | 2014 | 8317 | 0.110 |
Why?
|
Cell Survival | 6 | 2015 | 5794 | 0.110 |
Why?
|
Stromal Cells | 7 | 2013 | 1337 | 0.110 |
Why?
|
Genes, ras | 1 | 2015 | 665 | 0.100 |
Why?
|
Antibodies, Neutralizing | 2 | 2013 | 2009 | 0.100 |
Why?
|
Cyclohexanones | 1 | 2012 | 30 | 0.100 |
Why?
|
Down-Regulation | 5 | 2011 | 2941 | 0.100 |
Why?
|
Bone Diseases | 1 | 2016 | 416 | 0.100 |
Why?
|
Benzamides | 2 | 2015 | 1387 | 0.100 |
Why?
|
Tumor Microenvironment | 2 | 2016 | 3951 | 0.100 |
Why?
|
Acrylamides | 1 | 2014 | 261 | 0.100 |
Why?
|
Epoxy Compounds | 1 | 2012 | 137 | 0.100 |
Why?
|
Receptors, CCR1 | 2 | 2011 | 30 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 4 | 2013 | 5707 | 0.100 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2014 | 296 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2016 | 3608 | 0.090 |
Why?
|
Imidazoles | 3 | 2015 | 1169 | 0.090 |
Why?
|
MAP Kinase Signaling System | 2 | 2015 | 1494 | 0.090 |
Why?
|
Plasma Cells | 1 | 2014 | 599 | 0.090 |
Why?
|
Animals | 24 | 2016 | 169408 | 0.090 |
Why?
|
Calcification, Physiologic | 1 | 2011 | 171 | 0.090 |
Why?
|
Osteocalcin | 1 | 2011 | 277 | 0.090 |
Why?
|
Endoribonucleases | 1 | 2012 | 231 | 0.090 |
Why?
|
Benzimidazoles | 2 | 2015 | 864 | 0.080 |
Why?
|
Caspases | 2 | 2010 | 881 | 0.080 |
Why?
|
Neoplasm Transplantation | 4 | 2016 | 2018 | 0.080 |
Why?
|
Flavones | 1 | 2009 | 66 | 0.080 |
Why?
|
Maytansine | 1 | 2009 | 88 | 0.080 |
Why?
|
Cerulenin | 1 | 2008 | 7 | 0.080 |
Why?
|
Prednisolone | 1 | 2009 | 327 | 0.080 |
Why?
|
Syndecan-1 | 1 | 2009 | 163 | 0.080 |
Why?
|
Glycoproteins | 1 | 2016 | 2202 | 0.080 |
Why?
|
Interleukin-6 | 4 | 2012 | 3233 | 0.070 |
Why?
|
Melphalan | 1 | 2009 | 421 | 0.070 |
Why?
|
Azepines | 1 | 2010 | 329 | 0.070 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 414 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2010 | 1942 | 0.070 |
Why?
|
RNA Splicing | 1 | 2012 | 905 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2672 | 0.070 |
Why?
|
Albumins | 1 | 2010 | 577 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1886 | 0.070 |
Why?
|
Cyclin D1 | 1 | 2009 | 453 | 0.070 |
Why?
|
Bone Marrow | 2 | 2015 | 2935 | 0.070 |
Why?
|
Autophagy | 2 | 2015 | 1351 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2009 | 752 | 0.060 |
Why?
|
Immunologic Factors | 2 | 2017 | 1597 | 0.060 |
Why?
|
Humans | 39 | 2024 | 768887 | 0.060 |
Why?
|
Ascorbic Acid | 1 | 2009 | 658 | 0.060 |
Why?
|
RNA Polymerase II | 1 | 2010 | 549 | 0.060 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2009 | 622 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2433 | 0.060 |
Why?
|
Diphosphonates | 1 | 2009 | 634 | 0.060 |
Why?
|
Osteogenesis | 1 | 2011 | 1295 | 0.060 |
Why?
|
NF-kappa B | 1 | 2012 | 2492 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2013 | 2059 | 0.050 |
Why?
|
Cell Cycle | 4 | 2014 | 2937 | 0.050 |
Why?
|
Doxorubicin | 3 | 2015 | 2234 | 0.050 |
Why?
|
Tumor Cells, Cultured | 4 | 2012 | 6131 | 0.050 |
Why?
|
Mutation | 2 | 2024 | 30266 | 0.050 |
Why?
|
Immunoconjugates | 1 | 2009 | 976 | 0.050 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2009 | 1535 | 0.050 |
Why?
|
Blotting, Western | 3 | 2017 | 5035 | 0.050 |
Why?
|
Piperidines | 1 | 2010 | 1669 | 0.050 |
Why?
|
Antioxidants | 1 | 2009 | 1673 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2024 | 2059 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2017 | 1608 | 0.040 |
Why?
|
Cell Lineage | 1 | 2009 | 2576 | 0.040 |
Why?
|
Cell Communication | 1 | 2007 | 1660 | 0.040 |
Why?
|
Bone and Bones | 1 | 2009 | 2589 | 0.040 |
Why?
|
Nanoparticles | 1 | 2010 | 1989 | 0.040 |
Why?
|
Transplantation, Heterologous | 3 | 2012 | 2395 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2011 | 8664 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2010 | 440 | 0.040 |
Why?
|
Cell Differentiation | 5 | 2014 | 11684 | 0.030 |
Why?
|
Disease Progression | 2 | 2014 | 13677 | 0.030 |
Why?
|
Prognosis | 3 | 2024 | 30044 | 0.030 |
Why?
|
Transcription Factors | 2 | 2012 | 12174 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9618 | 0.030 |
Why?
|
Male | 10 | 2024 | 365249 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 303 | 0.030 |
Why?
|
Aged | 6 | 2024 | 171790 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2019 | 941 | 0.030 |
Why?
|
Phagosomes | 1 | 2015 | 198 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 381 | 0.030 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2014 | 199 | 0.030 |
Why?
|
Interleukin-3 | 1 | 2014 | 425 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2009 | 1339 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1216 | 0.030 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2012 | 68 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10276 | 0.030 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9549 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9264 | 0.020 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2014 | 179 | 0.020 |
Why?
|
Oxazines | 1 | 2014 | 358 | 0.020 |
Why?
|
Benzoquinones | 1 | 2012 | 198 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1839 | 0.020 |
Why?
|
eIF-2 Kinase | 1 | 2012 | 147 | 0.020 |
Why?
|
Cell Adhesion | 2 | 2009 | 3102 | 0.020 |
Why?
|
Retinal Pigment Epithelium | 1 | 2014 | 309 | 0.020 |
Why?
|
Lentivirus | 1 | 2014 | 520 | 0.020 |
Why?
|
RANK Ligand | 1 | 2012 | 321 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2013 | 457 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2012 | 319 | 0.020 |
Why?
|
Unfolded Protein Response | 1 | 2012 | 239 | 0.020 |
Why?
|
Bone Resorption | 1 | 2014 | 728 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2010 | 144 | 0.020 |
Why?
|
Cell Line | 2 | 2014 | 15603 | 0.020 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2010 | 178 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2009 | 53 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2011 | 491 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2012 | 1705 | 0.020 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2010 | 330 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 615 | 0.020 |
Why?
|
Adult | 5 | 2024 | 223818 | 0.020 |
Why?
|
Caspase 9 | 1 | 2008 | 184 | 0.020 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2008 | 147 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2014 | 1320 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2012 | 2299 | 0.020 |
Why?
|
Caspase 8 | 1 | 2008 | 198 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10778 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2475 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2010 | 640 | 0.020 |
Why?
|
Genes, fos | 1 | 2007 | 176 | 0.020 |
Why?
|
Female | 7 | 2024 | 397464 | 0.020 |
Why?
|
Cell Fusion | 1 | 2007 | 294 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2012 | 12809 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59738 | 0.020 |
Why?
|
Drug Evaluation | 1 | 2008 | 642 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2011 | 875 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1682 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10591 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 223740 | 0.020 |
Why?
|
Actins | 1 | 2014 | 2065 | 0.020 |
Why?
|
Cell Division | 1 | 2013 | 4478 | 0.020 |
Why?
|
Caspase 3 | 1 | 2008 | 731 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2911 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 1169 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2012 | 1855 | 0.020 |
Why?
|
Retinoblastoma Protein | 1 | 2009 | 673 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18366 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2013 | 19023 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3421 | 0.010 |
Why?
|
Bone Density Conservation Agents | 1 | 2009 | 797 | 0.010 |
Why?
|
United States | 2 | 2021 | 73180 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8512 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3724 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5520 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2010 | 2211 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2820 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2431 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11119 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3811 | 0.010 |
Why?
|
Mesenchymal Stem Cells | 1 | 2011 | 1672 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2813 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41800 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 3836 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2238 | 0.010 |
Why?
|
Bone Density | 1 | 2009 | 3573 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2014 | 65485 | 0.010 |
Why?
|
Cell Movement | 1 | 2007 | 5216 | 0.010 |
Why?
|
Cytokines | 1 | 2010 | 7453 | 0.010 |
Why?
|
Models, Biological | 1 | 2011 | 9499 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 5342 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22381 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 40266 | 0.000 |
Why?
|